Late Breaking Original Research
Tuesday, November 14, 2023
08:30 AM–10:00 AM
Abstract
Introduction: Prescribed medications are delivered to hospitalized patients before discharge using meds-to-beds programs. The data is mixed on whether meds-to-beds programs reduce readmissions. This study evaluates the impact of a meds-to-bed program on readmissions.
Research Question or Hypothesis: Does a meds-to-beds program at an academic medical center reduce readmission rates?
Study Design: We conducted a retrospective cohort study of patients admitted from 01/01/2022-07/30/2022 and compared the readmission data for patients who received meds-to-beds with patients who did not (non-meds-to-bed group).
Methods: The primary outcome was the readmission rate to the hospital or emergency department (ED) within 30 days. Secondary outcomes included 7-day readmission rates, 60-day readmission rates, and 7-day fill history for non-meds-to-beds patients. We compared readmission rates by using a logistic regression model.
Results: A total of 768 patients were included with 384 patients in each group. Overall, the patients had a mean age of 59.5 years-old, 54% were male, and 90.8% had insurance. The patients who received meds-to-beds were younger (p<0.0001), less likely to be female (39.3% vs. 52.6%, p=0.0003), and were more likely to be uninsured (15.4% vs. 2.9%, p<0.0001). Patients in the non-meds-to-beds group had higher odds of readmission between 0-30 days than patients who received meds-to-beds (OR 2.425; 95% CI 1.674-3.514, p<0.0001). For secondary outcomes, non-meds-to-beds patients had higher odds of readmission from 0-7 days (OR 4.2; 95% CI 2.331-7.569) and from 0-60 days (OR 1.747; 95% CI 1.244-2.455) than patients who received meds-to-beds. Insurance status was not significantly associated with 30-day readmission (p=.0916). The 7-day fills in the non-meds-to-bed group was 70.8% (any medication) and 46.4% (high-risk medications).
Conclusion: Patients who received meds-to-beds had significantly lower odds of being readmitted at 7 days, 30 days, and 60 days compared with patients who did not use the meds-to-beds program.
Presenting Author
Carrie Tilton PharmDAuthors
Marion Javellana PharmD
Mercer University College of Pharmacy
Nicole L. Metzger PharmD
Mercer University College of Pharmacy
Natalie Delozier PharmD
Emory University Hospital